American biomedical engineer
David A. Edwards (born April 6, 1961) is an American biomedical engineer , and the founder of Sensory Cloud.[ 1] [ 2] He was the Gordon McKay Professor of the Practice of Biomedical Engineering at Harvard University .[ 3] [ 4]
Edwards designs inhalable medicines, vaccines and victuals .[ 5] [ 6] [ 7]
In 2001, Edwards was elected a member of the National Academy of Engineering for transfer of scientific principles of engineering to industry, including invention and commercial development of a novel, generic aerosol drug-delivery system.
^ Osgood, Charles; Braver, Rita (27 September 2015). "Does a degree in chemical engineering guarantee that its holder will enjoy the sweet smell of success?" . CBS Sunday Morning. Retrieved 23 September 2020 .
^ Pelekanos, Adelle C. (Spring 2008). "Creativity after Google" (PDF) . New York Academy of Sciences Magazine . Retrieved 25 September 2020 .
^ Bradt, Steve (13 March 2008). "Inhaled TB vaccine more effective than traditional shot" . The Harvard Gazette . Retrieved 23 September 2020 .
^ Etherington, Darrell (8 July 2020). "Harvard biomedical engineering professor to launch nasal spray that could reduce COVID-19 transmission risk" . TechCrunch . Retrieved 23 September 2020 .
^ Lazar, Kay (10 April 2009). "Need a Puff of Chocolate? Inhaler Delivers Calorie-free Mist into Your Mouth" . The Boston Globe . Retrieved 23 September 2020 .
^ Wilson, Mark (8 July 2020). "Harvard professor develops a $50 nasal spray to thwart the spread of COVID-19" . Fast Company . Retrieved 23 September 2020 .
^ Edwards, David A.; Hanes, Justin; Caponetti, Giovanni; Hrkach, Jeffrey; Ben-Jebria, Abdelaziz; Eskew, Mary Lou; Mintzes, Jeffrey; Deaver, Daniel; Lotan, Noah; Langer, Robert (20 June 1997). "Large Porous Particles for Pulmonary Drug Delivery" . Science . 276 (5320): 1868–1872. doi :10.1126/science.276.5320.1868 . PMID 9188534 .